|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/18 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 25/28 | (2006.01) |
| (11) | Number of the document | 3478712 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17736841.2 |
| Date of filing the European patent application | 2017-06-23 | |
| (97) | Date of publication of the European application | 2019-05-08 |
| (45) | Date of publication and mention of the grant of the patent | 2023-07-19 |
| (46) | Date of publication of the claims translation | 2023-08-25 |
| (86) | Number | PCT/US2017/038999 |
| Date | 2017-06-23 |
| (87) | Number | WO 2018/005282 |
| Date | 2018-01-04 |
| (30) | Number | Date | Country code |
| 201662357579 P | 2016-07-01 | US |
| (72) |
DEMATTOS, Ronald Bradley , US
IRIZARRY, Michael Carl , US
|
| (73) |
Eli Lilly and Company ,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Anti-beta amiloido peptido N3pGlu antikūnai ir jų panaudojimas |
| ANTI-N3PGLU AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 9 | 208.00 EUR |
| 2026-06-23 |